<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kuser-Abali G</submitter><funding>NIH/NCI</funding><funding>NCI NIH HHS</funding><pagination>3452-3457</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5879692</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>115(13)</volume><pubmed_abstract>Renewable tissues exhibit heightened sensitivity to DNA damage, which is thought to result from a high level of p53. However, cell proliferation in renewable tissues requires p53 down-regulation, creating an apparent discrepancy between the p53 level and elevated sensitivity to DNA damage. Using a combination of genetic mouse models and pharmacologic inhibitors, we demonstrate that it is p53-regulated MDM2 that functions together with MDMX to regulate DNA damage sensitivity by targeting EZH2 (enhancer of zeste homolog 2) for ubiquitination/degradation. As a methyltransferase, EZH2 promotes H3K27me3, and therefore chromatin compaction, to determine sensitivity to DNA damage. We demonstrate that genetic and pharmacologic interference of the association between MDM2 and MDMX stabilizes EZH2, </pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.</pubmed_title><pmcid>PMC5879692</pmcid><funding_grant_id>R01CA125144</funding_grant_id><funding_grant_id>R01CA85679</funding_grant_id><funding_grant_id>R01 CA125144</funding_grant_id><funding_grant_id>R01CA167814</funding_grant_id><funding_grant_id>R01 CA085679</funding_grant_id><funding_grant_id>R01 CA167814</funding_grant_id><pubmed_authors>Yuan ZM</pubmed_authors><pubmed_authors>Yan J</pubmed_authors><pubmed_authors>Little JB</pubmed_authors><pubmed_authors>Lim CB</pubmed_authors><pubmed_authors>Williamson A</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Gong L</pubmed_authors><pubmed_authors>Molloy ME</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Kuser-Abali G</pubmed_authors><pubmed_authors>Zeng W</pubmed_authors></additional><is_claimable>false</is_claimable><name>An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.</name><description>Renewable tissues exhibit heightened sensitivity to DNA damage, which is thought to result from a high level of p53. However, cell proliferation in renewable tissues requires p53 down-regulation, creating an apparent discrepancy between the p53 level and elevated sensitivity to DNA damage. Using a combination of genetic mouse models and pharmacologic inhibitors, we demonstrate that it is p53-regulated MDM2 that functions together with MDMX to regulate DNA damage sensitivity by targeting EZH2 (enhancer of zeste homolog 2) for ubiquitination/degradation. As a methyltransferase, EZH2 promotes H3K27me3, and therefore chromatin compaction, to determine sensitivity to DNA damage. We demonstrate that genetic and pharmacologic interference of the association between MDM2 and MDMX stabilizes EZH2, </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2026-05-05T21:22:54.372Z</modification><creation>2019-03-26T23:57:06Z</creation></dates><accession>S-EPMC5879692</accession><cross_references><pubmed>29540569</pubmed><doi>10.1073/pnas.1719532115</doi></cross_references></HashMap>